Chemours Co. (NYSE:CC) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday. The firm currently has a $24.00 price objective on the stock. Zacks Investment Research’s price objective would suggest a potential upside of 15.89% from the stock’s previous close.

According to Zacks, “Chemours Company is involved in chemical business. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. Titanium Technologies segment produces titanium dioxide and premium white pigment. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins. Chemical Solutions segment provides industrial and specialty chemicals. The company’s brand consists of Teflon(R), Ti-Pure(R), Krytox(R) Viton(R), Opteon(R) and Nafion(R). Chemours Company is headquartered in Wilmington. “

A number of other analysts also recently issued reports on CC. TheStreet raised Chemours from a “sell” rating to a “hold” rating in a research report on Tuesday, August 9th. Jefferies Group reissued a “hold” rating and set a $17.00 price target (up previously from $15.00) on shares of Chemours in a research report on Thursday. Citigroup Inc. reissued a “neutral” rating and set a $9.00 price target (down previously from $10.50) on shares of Chemours in a research report on Friday, July 15th. Finally, Argus raised Chemours from a “hold” rating to a “buy” rating and set a $13.00 price target on the stock in a research report on Wednesday, August 10th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Chemours has an average rating of “Hold” and an average price target of $13.65.

Analyst Recommendations for Chemours (NYSE:CC)

Shares of Chemours (NYSE:CC) opened at 20.71 on Thursday. The firm has a market cap of $3.77 billion, a P/E ratio of 25.07 and a beta of 3.09. The firm has a 50-day moving average price of $16.57 and a 200-day moving average price of $11.85. Chemours has a 12-month low of $3.06 and a 12-month high of $21.34.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Thursday, November 17th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend is Tuesday, November 15th. Chemours’s dividend payout ratio (DPR) is presently 14.81%.

Large investors have recently modified their holdings of the company. Teachers Advisors Inc. boosted its stake in shares of Chemours by 9.5% in the first quarter. Teachers Advisors Inc. now owns 171,001 shares of the company’s stock worth $1,197,000 after buying an additional 14,837 shares in the last quarter. BlackRock Fund Advisors boosted its stake in shares of Chemours by 52.9% in the first quarter. BlackRock Fund Advisors now owns 8,170,493 shares of the company’s stock worth $57,193,000 after buying an additional 2,825,161 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Chemours by 6,564.4% in the first quarter. JPMorgan Chase & Co. now owns 342,018 shares of the company’s stock worth $2,395,000 after buying an additional 336,886 shares in the last quarter. UBS Asset Management Americas Inc. boosted its stake in shares of Chemours by 33.4% in the first quarter. UBS Asset Management Americas Inc. now owns 250,743 shares of the company’s stock worth $1,755,000 after buying an additional 62,822 shares in the last quarter. Finally, Kennedy Capital Management Inc. boosted its stake in shares of Chemours by 41.8% in the first quarter. Kennedy Capital Management Inc. now owns 21,662 shares of the company’s stock worth $152,000 after buying an additional 6,384 shares in the last quarter. Institutional investors own 76.69% of the company’s stock.

About Chemours

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Company’s Titanium Technologies segment manufactures titanium dioxide (TiO2), which is a pigment used to deliver whiteness, opacity, brightness and protection from sunlight in applications, such as architectural and industrial coatings, plastic packaging, polyvinyl chloride (PVC) window profiles, laminate papers, coated paper and coated paperboard used for packaging.

5 Day Chart for NYSE:CC

Receive News & Stock Ratings for Chemours Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Co. and related stocks with our FREE daily email newsletter.